Skip to main content

Table 1 Relationship between AE2 expression and clinicopathological features of gastric cancer

From: Expression of AE1/p16 promoted degradation of AE2 in gastric cancer cells

Clinicopathological features No.a AE2 expression P value
Negative no. (%) Positive no. (%)
Mean ages (years)
 63.6 ± 12.8 174 119 55  
Age (years)     0.6247
  ≤ 65 87 61 (70.11) 26 (29.89)  
  > 65 87 58 (66.67) 29 (33.33)  
Gender     0.4655
 Male 107 71 (66.36) 36 (33.64)  
 Female 67 48 (71.64) 19 (28.36)  
Differentiation     0.0005
 Well or Moderately 72 39 (54.17) 33 (45.83)  
 Poorly 101 80 (79.21) 21 (20.79)  
Lymph metastasis     0.7668
 Negative 39 26 (66.67) 13 (33.33)  
 Positive 133 92 (69.17) 41 (30.83)  
TNM staging     0.0179
 I 20 9 (45.00) 11 (55.00)  
 II–IV 130 93 (71.54) 37 (28.46)  
Lauren classification     0.0002
 Intestinal type 66 37 (56.06) 29 (43.94)  
 Diffuse type 82 69 (84.15) 13 (15.85)  
  1. Values in parenthesis are percentage
  2. aThe data was partially analyzed due to the unparticular information